April 2, 2024 — A woman’s cardiovascular risk can rise sharply after she goes through menopause, quickly catching up to ...
April 2, 2024 — Individuals with heart disease stand to gain the most from a low sodium diet but, on average, consume ...
April 2, 2024 — Medical device technology developer Concept Medical has announced it has been granted Investigational ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...
April 2, 2024 — Abbott announced that the U.S. Food and Drug Administration (FDA) approved the company's first-of-its ...
April 1, 2024 — Esperion announced that the United States Food and Drug Administration (FDA) has approved broad new ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
April 1, 2024 — Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health ...
April 1, 2024 — Sleeping fewer than seven hours is associated with a higher risk of developing high blood pressure over ...
March 29, 2024 — Young adults who were prescribed stimulant medications for attention-deficit/hyperactivity disorder ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...
March 28, 2024 — Medtronic plc, a global leader in healthcare technology, announced that the United States Food and Drug ...
March 28, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
March 28, 2024 — Cleerly, the company on a mission to create a new standard of care to aid in the diagnosis of heart ...
March 27, 2024 — Johnson & Johnson has announced that the U.S. Food and Drug Administration (FDA) has approved OPSYNVI – ...
March 27, 2024 — Elixir Medical has announced it has been granted Breakthrough Device Designation by the U.S. Food and ...
April 02, 2024
